- GlobeNewswire•6 days ago
PARSIPPANY, N.J., Feb. 16, 2017-- Pacira Pharmaceuticals, Inc. today announced that financial results for the company’ s fourth quarter and year ended December 31, 2016 will be released before the market ...
- GlobeNewswire•7 days ago
PARSIPPANY, N.J., Feb. 15, 2017-- Pacira Pharmaceuticals, Inc. today announced that Pacira Pharmaceuticals management team is scheduled to participate in an analyst-led fireside chat at the 2017 RBC Capital ...
- Zacks•8 days ago
Pacira Pharmaceuticals (PCRX) warrants investors' attention based on moves in the options market lately.
PCRX : Summary for Pacira Pharmaceuticals, Inc. - Yahoo Finance
Pacira Pharmaceuticals, Inc. (PCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||42.50 x 100|
|Ask||57.00 x 600|
|Day's Range||42.65 - 44.95|
|52 Week Range||29.95 - 65.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-43.54|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|